Clinical Trials Insight: 700018927
Phase of Trial: Phase II
Latest Information Update: 12 Dec 2014
At a glance
- Drugs Odanacatib (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Merck & Co
- 06 Apr 2007 Status changed from suspended to discontinued, according to ClinicalTrials.gov.
- 01 Apr 2007 Status changed from recruiting to suspended, according to ClinicalTrials.gov.
- 23 Nov 2006 New trial record.